Furthermore, [DA] in the striatum following administration of levodopa only began to increase when the number of DAT expressing terminals in the striatum began to fall and dyskinesia (as measured by Abnormal Involuntary Movements Scale: AIMS) increased linearly with the increase in striatal [DA]. Here, SLC6A3 is linked to Dyskinesia.